000			01444 a2200409 4500
005			20250516014736.0
264		0	_c20111004
008			201110s 0 0 eng d
022			_a1460-2091
024	7		_a10.1093/jac/dkq446 _2doi
040			_aNLM _beng _cNLM
100	1		_aShorr, Andrew F
245	0	0	_aOutcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei. _h[electronic resource]
260			_bThe Journal of antimicrobial chemotherapy _cFeb 2011
300			_a375-80 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntifungal Agents _xtherapeutic use
650	0	4	_aCandida _xdrug effects
650	0	4	_aCandida glabrata _xdrug effects
650	0	4	_aCandidiasis _xdrug therapy
650	0	4	_aCaspofungin
650	0	4	_aDrug Resistance, Fungal
650	0	4	_aEchinocandins _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLipopeptides _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMicafungin
650	0	4	_aMiddle Aged
650	0	4	_aTreatment Outcome
700	1		_aWu, Chunzhang
700	1		_aKothari, Smita
773	0		_tThe Journal of antimicrobial chemotherapy _gvol. 66 _gno. 2 _gp. 375-80
856	4	0	_uhttps://doi.org/10.1093/jac/dkq446 _zAvailable from publisher's website
999			_c20438112 _d20438112